{"id": "test_3_0", "text": "Regulation of hairy and enhancer of split homologue-1 (@GENE$) by estradiol and all-trans retinoic acid affects proliferation of human @DISEASE$ cells.", "text_with_entity_marker": "Regulation of hairy and enhancer of split homologue-1 ([E1]@GENE$[/E1]) by estradiol and all-trans retinoic acid affects proliferation of human [E2]@DISEASE$[/E2] cells.", "text_with_typed_entity_marker": "Regulation of hairy and enhancer of split homologue-1 ([GENE]@GENE$[/GENE]) by estradiol and all-trans retinoic acid affects proliferation of human [DISEASE]@DISEASE$[/DISEASE] cells.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [55, 61], "entity_1_idx_in_text_with_entity_marker": [59, 65], "entity_1_idx_in_text_with_typed_entity_marker": [61, 67], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [135, 144], "entity_2_idx_in_text_with_entity_marker": [148, 157], "entity_2_idx_in_text_with_typed_entity_marker": [157, 166], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "test_3_1", "text": "Previous studies of the @DISEASE$ have shown that HLA and @GENE$ genetic variants influence disease progression and early viral load.", "text_with_entity_marker": "Previous studies of the [E1]@DISEASE$[/E1] have shown that HLA and [E2]@GENE$[/E2] genetic variants influence disease progression and early viral load.", "text_with_typed_entity_marker": "Previous studies of the [DISEASE]@DISEASE$[/DISEASE] have shown that HLA and [GENE]@GENE$[/GENE] genetic variants influence disease progression and early viral load.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@DISEASE$", "entity_1_idx": [24, 33], "entity_1_idx_in_text_with_entity_marker": [28, 37], "entity_1_idx_in_text_with_typed_entity_marker": [33, 42], "entity_1_type": "DISEASE", "entity_1_type_id": 1, "entity_2": "@GENE$", "entity_2_idx": [58, 64], "entity_2_idx_in_text_with_entity_marker": [71, 77], "entity_2_idx_in_text_with_typed_entity_marker": [83, 89], "entity_2_type": "GENE", "entity_2_type_id": 0}]}
{"id": "test_3_2", "text": "Furthermore, we show that the HIV-DNA levels (reflecting the @DISEASE$ reservoir) are associated with the same four SNPs, but also with two additional SNPs on chromosome 17 (rs6503919; intergenic region flanked by the DDX40 and YPEL2 genes) and chromosome 8 (rs2575735; within the @GENE$ gene).", "text_with_entity_marker": "Furthermore, we show that the HIV-DNA levels (reflecting the [E1]@DISEASE$[/E1] reservoir) are associated with the same four SNPs, but also with two additional SNPs on chromosome 17 (rs6503919; intergenic region flanked by the DDX40 and YPEL2 genes) and chromosome 8 (rs2575735; within the [E2]@GENE$[/E2] gene).", "text_with_typed_entity_marker": "Furthermore, we show that the HIV-DNA levels (reflecting the [DISEASE]@DISEASE$[/DISEASE] reservoir) are associated with the same four SNPs, but also with two additional SNPs on chromosome 17 (rs6503919; intergenic region flanked by the DDX40 and YPEL2 genes) and chromosome 8 (rs2575735; within the [GENE]@GENE$[/GENE] gene).", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@DISEASE$", "entity_1_idx": [61, 70], "entity_1_idx_in_text_with_entity_marker": [65, 74], "entity_1_idx_in_text_with_typed_entity_marker": [70, 79], "entity_1_type": "DISEASE", "entity_1_type_id": 1, "entity_2": "@GENE$", "entity_2_idx": [281, 287], "entity_2_idx_in_text_with_entity_marker": [294, 300], "entity_2_idx_in_text_with_typed_entity_marker": [306, 312], "entity_2_type": "GENE", "entity_2_type_id": 0}]}
{"id": "test_3_3", "text": "Moreover, protective alleles for four disease-associated SNPs in the MHC locus (@GENE$, rs13199524, rs12198173 and rs3093662) were strikingly over-represented among forty-five Long Term @DISEASE$ controllers.", "text_with_entity_marker": "Moreover, protective alleles for four disease-associated SNPs in the MHC locus ([E1]@GENE$[/E1], rs13199524, rs12198173 and rs3093662) were strikingly over-represented among forty-five Long Term [E2]@DISEASE$[/E2] controllers.", "text_with_typed_entity_marker": "Moreover, protective alleles for four disease-associated SNPs in the MHC locus ([GENE]@GENE$[/GENE], rs13199524, rs12198173 and rs3093662) were strikingly over-represented among forty-five Long Term [DISEASE]@DISEASE$[/DISEASE] controllers.", "relation": [{"relation_type": "negative", "relation_id": 0, "entity_1": "@GENE$", "entity_1_idx": [80, 86], "entity_1_idx_in_text_with_entity_marker": [84, 90], "entity_1_idx_in_text_with_typed_entity_marker": [86, 92], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [186, 195], "entity_2_idx_in_text_with_entity_marker": [199, 208], "entity_2_idx_in_text_with_typed_entity_marker": [208, 217], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "test_3_4", "text": "Previous studies of the @DISEASE$ have shown that @GENE$ and Chemokine receptor genetic variants influence disease progression and early viral load.", "text_with_entity_marker": "Previous studies of the [E1]@DISEASE$[/E1] have shown that [E2]@GENE$[/E2] and Chemokine receptor genetic variants influence disease progression and early viral load.", "text_with_typed_entity_marker": "Previous studies of the [DISEASE]@DISEASE$[/DISEASE] have shown that [GENE]@GENE$[/GENE] and Chemokine receptor genetic variants influence disease progression and early viral load.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@DISEASE$", "entity_1_idx": [24, 33], "entity_1_idx_in_text_with_entity_marker": [28, 37], "entity_1_idx_in_text_with_typed_entity_marker": [33, 42], "entity_1_type": "DISEASE", "entity_1_type_id": 1, "entity_2": "@GENE$", "entity_2_idx": [50, 56], "entity_2_idx_in_text_with_entity_marker": [63, 69], "entity_2_idx_in_text_with_typed_entity_marker": [75, 81], "entity_2_type": "GENE", "entity_2_type_id": 0}]}
{"id": "test_3_5", "text": "Furthermore, we show that the HIV-DNA levels (reflecting the @DISEASE$ reservoir) are associated with the same four SNPs, but also with two additional SNPs on chromosome 17 (rs6503919; intergenic region flanked by the DDX40 and YPEL2 genes) and chromosome 8 (@GENE$; within the Syndecan 2 gene).", "text_with_entity_marker": "Furthermore, we show that the HIV-DNA levels (reflecting the [E1]@DISEASE$[/E1] reservoir) are associated with the same four SNPs, but also with two additional SNPs on chromosome 17 (rs6503919; intergenic region flanked by the DDX40 and YPEL2 genes) and chromosome 8 ([E2]@GENE$[/E2]; within the Syndecan 2 gene).", "text_with_typed_entity_marker": "Furthermore, we show that the HIV-DNA levels (reflecting the [DISEASE]@DISEASE$[/DISEASE] reservoir) are associated with the same four SNPs, but also with two additional SNPs on chromosome 17 (rs6503919; intergenic region flanked by the DDX40 and YPEL2 genes) and chromosome 8 ([GENE]@GENE$[/GENE]; within the Syndecan 2 gene).", "relation": [{"relation_type": "negative", "relation_id": 0, "entity_1": "@DISEASE$", "entity_1_idx": [61, 70], "entity_1_idx_in_text_with_entity_marker": [65, 74], "entity_1_idx_in_text_with_typed_entity_marker": [70, 79], "entity_1_type": "DISEASE", "entity_1_type_id": 1, "entity_2": "@GENE$", "entity_2_idx": [259, 265], "entity_2_idx_in_text_with_entity_marker": [272, 278], "entity_2_idx_in_text_with_typed_entity_marker": [284, 290], "entity_2_type": "GENE", "entity_2_type_id": 0}]}
{"id": "test_3_6", "text": "Moreover, protective alleles for four disease-associated SNPs in the @GENE$ locus (rs2395029, rs13199524, rs12198173 and rs3093662) were strikingly over-represented among forty-five Long Term @DISEASE$ controllers.", "text_with_entity_marker": "Moreover, protective alleles for four disease-associated SNPs in the [E1]@GENE$[/E1] locus (rs2395029, rs13199524, rs12198173 and rs3093662) were strikingly over-represented among forty-five Long Term [E2]@DISEASE$[/E2] controllers.", "text_with_typed_entity_marker": "Moreover, protective alleles for four disease-associated SNPs in the [GENE]@GENE$[/GENE] locus (rs2395029, rs13199524, rs12198173 and rs3093662) were strikingly over-represented among forty-five Long Term [DISEASE]@DISEASE$[/DISEASE] controllers.", "relation": [{"relation_type": "negative", "relation_id": 0, "entity_1": "@GENE$", "entity_1_idx": [69, 75], "entity_1_idx_in_text_with_entity_marker": [73, 79], "entity_1_idx_in_text_with_typed_entity_marker": [75, 81], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [192, 201], "entity_2_idx_in_text_with_entity_marker": [205, 214], "entity_2_idx_in_text_with_typed_entity_marker": [214, 223], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "test_3_7", "text": "Moreover, protective alleles for four disease-associated SNPs in the MHC locus (rs2395029, rs13199524, rs12198173 and @GENE$) were strikingly over-represented among forty-five Long Term @DISEASE$ controllers.", "text_with_entity_marker": "Moreover, protective alleles for four disease-associated SNPs in the MHC locus (rs2395029, rs13199524, rs12198173 and [E1]@GENE$[/E1]) were strikingly over-represented among forty-five Long Term [E2]@DISEASE$[/E2] controllers.", "text_with_typed_entity_marker": "Moreover, protective alleles for four disease-associated SNPs in the MHC locus (rs2395029, rs13199524, rs12198173 and [GENE]@GENE$[/GENE]) were strikingly over-represented among forty-five Long Term [DISEASE]@DISEASE$[/DISEASE] controllers.", "relation": [{"relation_type": "negative", "relation_id": 0, "entity_1": "@GENE$", "entity_1_idx": [118, 124], "entity_1_idx_in_text_with_entity_marker": [122, 128], "entity_1_idx_in_text_with_typed_entity_marker": [124, 130], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [186, 195], "entity_2_idx_in_text_with_entity_marker": [199, 208], "entity_2_idx_in_text_with_typed_entity_marker": [208, 217], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "test_3_8", "text": "Our data provide evidence that the @GENE$ controls both HIV replication and @DISEASE$ reservoir.", "text_with_entity_marker": "Our data provide evidence that the [E1]@GENE$[/E1] controls both HIV replication and [E2]@DISEASE$[/E2] reservoir.", "text_with_typed_entity_marker": "Our data provide evidence that the [GENE]@GENE$[/GENE] controls both HIV replication and [DISEASE]@DISEASE$[/DISEASE] reservoir.", "relation": [{"relation_type": "negative", "relation_id": 0, "entity_1": "@GENE$", "entity_1_idx": [35, 41], "entity_1_idx_in_text_with_entity_marker": [39, 45], "entity_1_idx_in_text_with_typed_entity_marker": [41, 47], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [76, 85], "entity_2_idx_in_text_with_entity_marker": [89, 98], "entity_2_idx_in_text_with_typed_entity_marker": [98, 107], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "test_3_9", "text": "Moreover, protective alleles for four disease-associated SNPs in the MHC locus (rs2395029, rs13199524, @GENE$ and rs3093662) were strikingly over-represented among forty-five Long Term @DISEASE$ controllers.", "text_with_entity_marker": "Moreover, protective alleles for four disease-associated SNPs in the MHC locus (rs2395029, rs13199524, [E1]@GENE$[/E1] and rs3093662) were strikingly over-represented among forty-five Long Term [E2]@DISEASE$[/E2] controllers.", "text_with_typed_entity_marker": "Moreover, protective alleles for four disease-associated SNPs in the MHC locus (rs2395029, rs13199524, [GENE]@GENE$[/GENE] and rs3093662) were strikingly over-represented among forty-five Long Term [DISEASE]@DISEASE$[/DISEASE] controllers.", "relation": [{"relation_type": "negative", "relation_id": 0, "entity_1": "@GENE$", "entity_1_idx": [103, 109], "entity_1_idx_in_text_with_entity_marker": [107, 113], "entity_1_idx_in_text_with_typed_entity_marker": [109, 115], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [185, 194], "entity_2_idx_in_text_with_entity_marker": [198, 207], "entity_2_idx_in_text_with_typed_entity_marker": [207, 216], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "test_3_10", "text": "Furthermore, we show that the HIV-DNA levels (reflecting the @DISEASE$ reservoir) are associated with the same four SNPs, but also with two additional SNPs on chromosome 17 (@GENE$; intergenic region flanked by the DDX40 and YPEL2 genes) and chromosome 8 (rs2575735; within the Syndecan 2 gene).", "text_with_entity_marker": "Furthermore, we show that the HIV-DNA levels (reflecting the [E1]@DISEASE$[/E1] reservoir) are associated with the same four SNPs, but also with two additional SNPs on chromosome 17 ([E2]@GENE$[/E2]; intergenic region flanked by the DDX40 and YPEL2 genes) and chromosome 8 (rs2575735; within the Syndecan 2 gene).", "text_with_typed_entity_marker": "Furthermore, we show that the HIV-DNA levels (reflecting the [DISEASE]@DISEASE$[/DISEASE] reservoir) are associated with the same four SNPs, but also with two additional SNPs on chromosome 17 ([GENE]@GENE$[/GENE]; intergenic region flanked by the DDX40 and YPEL2 genes) and chromosome 8 (rs2575735; within the Syndecan 2 gene).", "relation": [{"relation_type": "negative", "relation_id": 0, "entity_1": "@DISEASE$", "entity_1_idx": [61, 70], "entity_1_idx_in_text_with_entity_marker": [65, 74], "entity_1_idx_in_text_with_typed_entity_marker": [70, 79], "entity_1_type": "DISEASE", "entity_1_type_id": 1, "entity_2": "@GENE$", "entity_2_idx": [174, 180], "entity_2_idx_in_text_with_entity_marker": [187, 193], "entity_2_idx_in_text_with_typed_entity_marker": [199, 205], "entity_2_type": "GENE", "entity_2_type_id": 0}]}
{"id": "test_3_11", "text": "The commonly deleted region of the @DISEASE$ extends between the genes @GENE$ (proximal boundary) and GLRA1 (distal boundary) and measures 2.9 Mb.", "text_with_entity_marker": "The commonly deleted region of the [E1]@DISEASE$[/E1] extends between the genes [E2]@GENE$[/E2] (proximal boundary) and GLRA1 (distal boundary) and measures 2.9 Mb.", "text_with_typed_entity_marker": "The commonly deleted region of the [DISEASE]@DISEASE$[/DISEASE] extends between the genes [GENE]@GENE$[/GENE] (proximal boundary) and GLRA1 (distal boundary) and measures 2.9 Mb.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@DISEASE$", "entity_1_idx": [35, 44], "entity_1_idx_in_text_with_entity_marker": [39, 48], "entity_1_idx_in_text_with_typed_entity_marker": [44, 53], "entity_1_type": "DISEASE", "entity_1_type_id": 1, "entity_2": "@GENE$", "entity_2_idx": [71, 77], "entity_2_idx_in_text_with_entity_marker": [84, 90], "entity_2_idx_in_text_with_typed_entity_marker": [96, 102], "entity_2_type": "GENE", "entity_2_type_id": 0}]}
{"id": "test_3_12", "text": "The commonly deleted region of the @DISEASE$ extends between the genes SH3TC2 (proximal boundary) and @GENE$ (distal boundary) and measures 2.9 Mb.", "text_with_entity_marker": "The commonly deleted region of the [E1]@DISEASE$[/E1] extends between the genes SH3TC2 (proximal boundary) and [E2]@GENE$[/E2] (distal boundary) and measures 2.9 Mb.", "text_with_typed_entity_marker": "The commonly deleted region of the [DISEASE]@DISEASE$[/DISEASE] extends between the genes SH3TC2 (proximal boundary) and [GENE]@GENE$[/GENE] (distal boundary) and measures 2.9 Mb.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@DISEASE$", "entity_1_idx": [35, 44], "entity_1_idx_in_text_with_entity_marker": [39, 48], "entity_1_idx_in_text_with_typed_entity_marker": [44, 53], "entity_1_type": "DISEASE", "entity_1_type_id": 1, "entity_2": "@GENE$", "entity_2_idx": [102, 108], "entity_2_idx_in_text_with_entity_marker": [115, 121], "entity_2_idx_in_text_with_typed_entity_marker": [127, 133], "entity_2_type": "GENE", "entity_2_type_id": 0}]}
{"id": "test_3_13", "text": "Aberrant expression of chitinase 3-like 1 (CHI3L1), also known as YKL-40 or @GENE$, is involved in the pathogenesis of @DISEASE$.", "text_with_entity_marker": "Aberrant expression of chitinase 3-like 1 (CHI3L1), also known as YKL-40 or [E1]@GENE$[/E1], is involved in the pathogenesis of [E2]@DISEASE$[/E2].", "text_with_typed_entity_marker": "Aberrant expression of chitinase 3-like 1 (CHI3L1), also known as YKL-40 or [GENE]@GENE$[/GENE], is involved in the pathogenesis of [DISEASE]@DISEASE$[/DISEASE].", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [76, 82], "entity_1_idx_in_text_with_entity_marker": [80, 86], "entity_1_idx_in_text_with_typed_entity_marker": [82, 88], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [119, 128], "entity_2_idx_in_text_with_entity_marker": [132, 141], "entity_2_idx_in_text_with_typed_entity_marker": [141, 150], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "test_3_14", "text": "These results strongly suggest that the @GENE$ polymorphism in the CHI3L1 promoter region is associated with the risk of @DISEASE$.", "text_with_entity_marker": "These results strongly suggest that the [E1]@GENE$[/E1] polymorphism in the CHI3L1 promoter region is associated with the risk of [E2]@DISEASE$[/E2].", "text_with_typed_entity_marker": "These results strongly suggest that the [GENE]@GENE$[/GENE] polymorphism in the CHI3L1 promoter region is associated with the risk of [DISEASE]@DISEASE$[/DISEASE].", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [40, 46], "entity_1_idx_in_text_with_entity_marker": [44, 50], "entity_1_idx_in_text_with_typed_entity_marker": [46, 52], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [121, 130], "entity_2_idx_in_text_with_entity_marker": [134, 143], "entity_2_idx_in_text_with_typed_entity_marker": [143, 152], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "test_3_15", "text": "Genetic variation in the promoter region of @GENE$ is associated with @DISEASE$.", "text_with_entity_marker": "Genetic variation in the promoter region of [E1]@GENE$[/E1] is associated with [E2]@DISEASE$[/E2].", "text_with_typed_entity_marker": "Genetic variation in the promoter region of [GENE]@GENE$[/GENE] is associated with [DISEASE]@DISEASE$[/DISEASE].", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [44, 50], "entity_1_idx_in_text_with_entity_marker": [48, 54], "entity_1_idx_in_text_with_typed_entity_marker": [50, 56], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [70, 79], "entity_2_idx_in_text_with_entity_marker": [83, 92], "entity_2_idx_in_text_with_typed_entity_marker": [92, 101], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "test_3_16", "text": "In the case-control association analysis, the g.-247C/T polymorphism at the promoter region (rs10399805; P = 0.0062) and the @GENE$ polymorphism at intron 7 (rs2275353; P = 0.0056) of CHI3L1 showed a significant association with @DISEASE$.", "text_with_entity_marker": "In the case-control association analysis, the g.-247C/T polymorphism at the promoter region (rs10399805; P = 0.0062) and the [E1]@GENE$[/E1] polymorphism at intron 7 (rs2275353; P = 0.0056) of CHI3L1 showed a significant association with [E2]@DISEASE$[/E2].", "text_with_typed_entity_marker": "In the case-control association analysis, the g.-247C/T polymorphism at the promoter region (rs10399805; P = 0.0062) and the [GENE]@GENE$[/GENE] polymorphism at intron 7 (rs2275353; P = 0.0056) of CHI3L1 showed a significant association with [DISEASE]@DISEASE$[/DISEASE].", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [125, 131], "entity_1_idx_in_text_with_entity_marker": [129, 135], "entity_1_idx_in_text_with_typed_entity_marker": [131, 137], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [229, 238], "entity_2_idx_in_text_with_entity_marker": [242, 251], "entity_2_idx_in_text_with_typed_entity_marker": [251, 260], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "test_3_17", "text": "In the case-control association analysis, the g.-247C/T polymorphism at the promoter region (@GENE$; P = 0.0062) and the IVS7+82C/T polymorphism at intron 7 (rs2275353; P = 0.0056) of CHI3L1 showed a significant association with @DISEASE$.", "text_with_entity_marker": "In the case-control association analysis, the g.-247C/T polymorphism at the promoter region ([E1]@GENE$[/E1]; P = 0.0062) and the IVS7+82C/T polymorphism at intron 7 (rs2275353; P = 0.0056) of CHI3L1 showed a significant association with [E2]@DISEASE$[/E2].", "text_with_typed_entity_marker": "In the case-control association analysis, the g.-247C/T polymorphism at the promoter region ([GENE]@GENE$[/GENE]; P = 0.0062) and the IVS7+82C/T polymorphism at intron 7 (rs2275353; P = 0.0056) of CHI3L1 showed a significant association with [DISEASE]@DISEASE$[/DISEASE].", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [93, 99], "entity_1_idx_in_text_with_entity_marker": [97, 103], "entity_1_idx_in_text_with_typed_entity_marker": [99, 105], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [229, 238], "entity_2_idx_in_text_with_entity_marker": [242, 251], "entity_2_idx_in_text_with_typed_entity_marker": [251, 260], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "test_3_18", "text": "These results strongly suggest that the g.-247C/T polymorphism in the @GENE$ promoter region is associated with the risk of @DISEASE$.", "text_with_entity_marker": "These results strongly suggest that the g.-247C/T polymorphism in the [E1]@GENE$[/E1] promoter region is associated with the risk of [E2]@DISEASE$[/E2].", "text_with_typed_entity_marker": "These results strongly suggest that the g.-247C/T polymorphism in the [GENE]@GENE$[/GENE] promoter region is associated with the risk of [DISEASE]@DISEASE$[/DISEASE].", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [70, 76], "entity_1_idx_in_text_with_entity_marker": [74, 80], "entity_1_idx_in_text_with_typed_entity_marker": [76, 82], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [124, 133], "entity_2_idx_in_text_with_entity_marker": [137, 146], "entity_2_idx_in_text_with_typed_entity_marker": [146, 155], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "test_3_19", "text": "The genetic contribution of @GENE$ gene to @DISEASE$ susceptibility was investigated using an integrated population genetic and molecular analysis.", "text_with_entity_marker": "The genetic contribution of [E1]@GENE$[/E1] gene to [E2]@DISEASE$[/E2] susceptibility was investigated using an integrated population genetic and molecular analysis.", "text_with_typed_entity_marker": "The genetic contribution of [GENE]@GENE$[/GENE] gene to [DISEASE]@DISEASE$[/DISEASE] susceptibility was investigated using an integrated population genetic and molecular analysis.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [28, 34], "entity_1_idx_in_text_with_entity_marker": [32, 38], "entity_1_idx_in_text_with_typed_entity_marker": [34, 40], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [43, 52], "entity_2_idx_in_text_with_entity_marker": [56, 65], "entity_2_idx_in_text_with_typed_entity_marker": [65, 74], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "test_3_20", "text": "Genetic variations in @GENE$ were identified and genotyped in 295 unrelated patients with @DISEASE$ and 180 control subjects.", "text_with_entity_marker": "Genetic variations in [E1]@GENE$[/E1] were identified and genotyped in 295 unrelated patients with [E2]@DISEASE$[/E2] and 180 control subjects.", "text_with_typed_entity_marker": "Genetic variations in [GENE]@GENE$[/GENE] were identified and genotyped in 295 unrelated patients with [DISEASE]@DISEASE$[/DISEASE] and 180 control subjects.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [22, 28], "entity_1_idx_in_text_with_entity_marker": [26, 32], "entity_1_idx_in_text_with_typed_entity_marker": [28, 34], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [90, 99], "entity_2_idx_in_text_with_entity_marker": [103, 112], "entity_2_idx_in_text_with_typed_entity_marker": [112, 121], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "test_3_21", "text": "In the case-control association analysis, the g.-247C/T polymorphism at the promoter region (rs10399805; P = 0.0062) and the IVS7+82C/T polymorphism at intron 7 (rs2275353; P = 0.0056) of @GENE$ showed a significant association with @DISEASE$.", "text_with_entity_marker": "In the case-control association analysis, the g.-247C/T polymorphism at the promoter region (rs10399805; P = 0.0062) and the IVS7+82C/T polymorphism at intron 7 (rs2275353; P = 0.0056) of [E1]@GENE$[/E1] showed a significant association with [E2]@DISEASE$[/E2].", "text_with_typed_entity_marker": "In the case-control association analysis, the g.-247C/T polymorphism at the promoter region (rs10399805; P = 0.0062) and the IVS7+82C/T polymorphism at intron 7 (rs2275353; P = 0.0056) of [GENE]@GENE$[/GENE] showed a significant association with [DISEASE]@DISEASE$[/DISEASE].", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [188, 194], "entity_1_idx_in_text_with_entity_marker": [192, 198], "entity_1_idx_in_text_with_typed_entity_marker": [194, 200], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [233, 242], "entity_2_idx_in_text_with_entity_marker": [246, 255], "entity_2_idx_in_text_with_typed_entity_marker": [255, 264], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "test_3_22", "text": "In the case-control association analysis, the g.-247C/T polymorphism at the promoter region (rs10399805; P = 0.0062) and the IVS7+82C/T polymorphism at intron 7 (@GENE$; P = 0.0056) of CHI3L1 showed a significant association with @DISEASE$.", "text_with_entity_marker": "In the case-control association analysis, the g.-247C/T polymorphism at the promoter region (rs10399805; P = 0.0062) and the IVS7+82C/T polymorphism at intron 7 ([E1]@GENE$[/E1]; P = 0.0056) of CHI3L1 showed a significant association with [E2]@DISEASE$[/E2].", "text_with_typed_entity_marker": "In the case-control association analysis, the g.-247C/T polymorphism at the promoter region (rs10399805; P = 0.0062) and the IVS7+82C/T polymorphism at intron 7 ([GENE]@GENE$[/GENE]; P = 0.0056) of CHI3L1 showed a significant association with [DISEASE]@DISEASE$[/DISEASE].", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [162, 168], "entity_1_idx_in_text_with_entity_marker": [166, 172], "entity_1_idx_in_text_with_typed_entity_marker": [168, 174], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [230, 239], "entity_2_idx_in_text_with_entity_marker": [243, 252], "entity_2_idx_in_text_with_typed_entity_marker": [252, 261], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "test_3_23", "text": "In the case-control association analysis, the @GENE$ polymorphism at the promoter region (rs10399805; P = 0.0062) and the IVS7+82C/T polymorphism at intron 7 (rs2275353; P = 0.0056) of CHI3L1 showed a significant association with @DISEASE$.", "text_with_entity_marker": "In the case-control association analysis, the [E1]@GENE$[/E1] polymorphism at the promoter region (rs10399805; P = 0.0062) and the IVS7+82C/T polymorphism at intron 7 (rs2275353; P = 0.0056) of CHI3L1 showed a significant association with [E2]@DISEASE$[/E2].", "text_with_typed_entity_marker": "In the case-control association analysis, the [GENE]@GENE$[/GENE] polymorphism at the promoter region (rs10399805; P = 0.0062) and the IVS7+82C/T polymorphism at intron 7 (rs2275353; P = 0.0056) of CHI3L1 showed a significant association with [DISEASE]@DISEASE$[/DISEASE].", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [46, 52], "entity_1_idx_in_text_with_entity_marker": [50, 56], "entity_1_idx_in_text_with_typed_entity_marker": [52, 58], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [230, 239], "entity_2_idx_in_text_with_entity_marker": [243, 252], "entity_2_idx_in_text_with_typed_entity_marker": [252, 261], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "test_3_24", "text": "In humans, loss-of-function of the cilia-centrosomal protein @GENE$ is associated with Joubert and Meckel syndromes, whereas hypomorphic mutations result in @DISEASE$ (LCA), a form of early-onset retinal dystrophy.", "text_with_entity_marker": "In humans, loss-of-function of the cilia-centrosomal protein [E1]@GENE$[/E1] is associated with Joubert and Meckel syndromes, whereas hypomorphic mutations result in [E2]@DISEASE$[/E2] (LCA), a form of early-onset retinal dystrophy.", "text_with_typed_entity_marker": "In humans, loss-of-function of the cilia-centrosomal protein [GENE]@GENE$[/GENE] is associated with Joubert and Meckel syndromes, whereas hypomorphic mutations result in [DISEASE]@DISEASE$[/DISEASE] (LCA), a form of early-onset retinal dystrophy.", "relation": [{"relation_type": "negative", "relation_id": 0, "entity_1": "@GENE$", "entity_1_idx": [61, 67], "entity_1_idx_in_text_with_entity_marker": [65, 71], "entity_1_idx_in_text_with_typed_entity_marker": [67, 73], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [157, 166], "entity_2_idx_in_text_with_entity_marker": [170, 179], "entity_2_idx_in_text_with_typed_entity_marker": [179, 188], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "test_3_25", "text": "Hypomorphic @GENE$/NPHP6 mutations result in @DISEASE$ caused by the selective loss of G proteins in cilia of olfactory sensory neurons.", "text_with_entity_marker": "Hypomorphic [E1]@GENE$[/E1]/NPHP6 mutations result in [E2]@DISEASE$[/E2] caused by the selective loss of G proteins in cilia of olfactory sensory neurons.", "text_with_typed_entity_marker": "Hypomorphic [GENE]@GENE$[/GENE]/NPHP6 mutations result in [DISEASE]@DISEASE$[/DISEASE] caused by the selective loss of G proteins in cilia of olfactory sensory neurons.", "relation": [{"relation_type": "negative", "relation_id": 0, "entity_1": "@GENE$", "entity_1_idx": [12, 18], "entity_1_idx_in_text_with_entity_marker": [16, 22], "entity_1_idx_in_text_with_typed_entity_marker": [18, 24], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [45, 54], "entity_2_idx_in_text_with_entity_marker": [58, 67], "entity_2_idx_in_text_with_typed_entity_marker": [67, 76], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "test_3_26", "text": "In humans, loss-of-function of the cilia-centrosomal protein @GENE$ is associated with Joubert and @DISEASE$, whereas hypomorphic mutations result in Leber congenital amaurosis (LCA), a form of early-onset retinal dystrophy.", "text_with_entity_marker": "In humans, loss-of-function of the cilia-centrosomal protein [E1]@GENE$[/E1] is associated with Joubert and [E2]@DISEASE$[/E2], whereas hypomorphic mutations result in Leber congenital amaurosis (LCA), a form of early-onset retinal dystrophy.", "text_with_typed_entity_marker": "In humans, loss-of-function of the cilia-centrosomal protein [GENE]@GENE$[/GENE] is associated with Joubert and [DISEASE]@DISEASE$[/DISEASE], whereas hypomorphic mutations result in Leber congenital amaurosis (LCA), a form of early-onset retinal dystrophy.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [61, 67], "entity_1_idx_in_text_with_entity_marker": [65, 71], "entity_1_idx_in_text_with_typed_entity_marker": [67, 73], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [99, 108], "entity_2_idx_in_text_with_entity_marker": [112, 121], "entity_2_idx_in_text_with_typed_entity_marker": [121, 130], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "test_3_27", "text": "In humans, loss-of-function of the cilia-centrosomal protein @GENE$ is associated with @DISEASE$ and Meckel syndromes, whereas hypomorphic mutations result in Leber congenital amaurosis (LCA), a form of early-onset retinal dystrophy.", "text_with_entity_marker": "In humans, loss-of-function of the cilia-centrosomal protein [E1]@GENE$[/E1] is associated with [E2]@DISEASE$[/E2] and Meckel syndromes, whereas hypomorphic mutations result in Leber congenital amaurosis (LCA), a form of early-onset retinal dystrophy.", "text_with_typed_entity_marker": "In humans, loss-of-function of the cilia-centrosomal protein [GENE]@GENE$[/GENE] is associated with [DISEASE]@DISEASE$[/DISEASE] and Meckel syndromes, whereas hypomorphic mutations result in Leber congenital amaurosis (LCA), a form of early-onset retinal dystrophy.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [61, 67], "entity_1_idx_in_text_with_entity_marker": [65, 71], "entity_1_idx_in_text_with_typed_entity_marker": [67, 73], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [87, 96], "entity_2_idx_in_text_with_entity_marker": [100, 109], "entity_2_idx_in_text_with_typed_entity_marker": [109, 118], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "test_3_28", "text": "Association between donor @GENE$ and graft survival and the development of @DISEASE$ after lung transplantation.", "text_with_entity_marker": "Association between donor [E1]@GENE$[/E1] and graft survival and the development of [E2]@DISEASE$[/E2] after lung transplantation.", "text_with_typed_entity_marker": "Association between donor [GENE]@GENE$[/GENE] and graft survival and the development of [DISEASE]@DISEASE$[/DISEASE] after lung transplantation.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [26, 32], "entity_1_idx_in_text_with_entity_marker": [30, 36], "entity_1_idx_in_text_with_typed_entity_marker": [32, 38], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [75, 84], "entity_2_idx_in_text_with_entity_marker": [88, 97], "entity_2_idx_in_text_with_typed_entity_marker": [97, 106], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "test_3_29", "text": "Compared with the epsilon3 homozygotes, neither the epsilon2 nor the @GENE$ carrier status was associated with @DISEASE$ (adjusted prevalence ratios = 0.94, 95%CI = 0.83-1.07 and 0.98, 0.89-1.07, respectively).", "text_with_entity_marker": "Compared with the epsilon3 homozygotes, neither the epsilon2 nor the [E1]@GENE$[/E1] carrier status was associated with [E2]@DISEASE$[/E2] (adjusted prevalence ratios = 0.94, 95%CI = 0.83-1.07 and 0.98, 0.89-1.07, respectively).", "text_with_typed_entity_marker": "Compared with the epsilon3 homozygotes, neither the epsilon2 nor the [GENE]@GENE$[/GENE] carrier status was associated with [DISEASE]@DISEASE$[/DISEASE] (adjusted prevalence ratios = 0.94, 95%CI = 0.83-1.07 and 0.98, 0.89-1.07, respectively).", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [69, 75], "entity_1_idx_in_text_with_entity_marker": [73, 79], "entity_1_idx_in_text_with_typed_entity_marker": [75, 81], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [111, 120], "entity_2_idx_in_text_with_entity_marker": [124, 133], "entity_2_idx_in_text_with_typed_entity_marker": [133, 142], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "test_3_30", "text": "Compared with the epsilon3 homozygotes, neither the @GENE$ nor the epsilon4 carrier status was associated with @DISEASE$ (adjusted prevalence ratios = 0.94, 95%CI = 0.83-1.07 and 0.98, 0.89-1.07, respectively).", "text_with_entity_marker": "Compared with the epsilon3 homozygotes, neither the [E1]@GENE$[/E1] nor the epsilon4 carrier status was associated with [E2]@DISEASE$[/E2] (adjusted prevalence ratios = 0.94, 95%CI = 0.83-1.07 and 0.98, 0.89-1.07, respectively).", "text_with_typed_entity_marker": "Compared with the epsilon3 homozygotes, neither the [GENE]@GENE$[/GENE] nor the epsilon4 carrier status was associated with [DISEASE]@DISEASE$[/DISEASE] (adjusted prevalence ratios = 0.94, 95%CI = 0.83-1.07 and 0.98, 0.89-1.07, respectively).", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [52, 58], "entity_1_idx_in_text_with_entity_marker": [56, 62], "entity_1_idx_in_text_with_typed_entity_marker": [58, 64], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [111, 120], "entity_2_idx_in_text_with_entity_marker": [124, 133], "entity_2_idx_in_text_with_typed_entity_marker": [133, 142], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "test_3_31", "text": "@GENE$ (ApoE) polymorphism influences lipid metabolism, but its association with @DISEASE$ is controversial.", "text_with_entity_marker": "[E1]@GENE$[/E1] (ApoE) polymorphism influences lipid metabolism, but its association with [E2]@DISEASE$[/E2] is controversial.", "text_with_typed_entity_marker": "[GENE]@GENE$[/GENE] (ApoE) polymorphism influences lipid metabolism, but its association with [DISEASE]@DISEASE$[/DISEASE] is controversial.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [0, 6], "entity_1_idx_in_text_with_entity_marker": [4, 10], "entity_1_idx_in_text_with_typed_entity_marker": [6, 12], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [81, 90], "entity_2_idx_in_text_with_entity_marker": [94, 103], "entity_2_idx_in_text_with_typed_entity_marker": [103, 112], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "test_3_32", "text": "This study provides epidemiologic evidence that the @GENE$ genotype is not associated with @DISEASE$ in old age.", "text_with_entity_marker": "This study provides epidemiologic evidence that the [E1]@GENE$[/E1] genotype is not associated with [E2]@DISEASE$[/E2] in old age.", "text_with_typed_entity_marker": "This study provides epidemiologic evidence that the [GENE]@GENE$[/GENE] genotype is not associated with [DISEASE]@DISEASE$[/DISEASE] in old age.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [52, 58], "entity_1_idx_in_text_with_entity_marker": [56, 62], "entity_1_idx_in_text_with_typed_entity_marker": [58, 64], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [91, 100], "entity_2_idx_in_text_with_entity_marker": [104, 113], "entity_2_idx_in_text_with_typed_entity_marker": [113, 122], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "test_3_33", "text": "Analysis yielded the following Yale-generated observations: (1) TAA is a genetic disease with a predominantly autosomal dominant mode of inheritance; (2) matrix metalloproteinase (@GENE$) enzymes are activated in the pathogenesis of TAA; (3) wall tension in TAA approaches the tensile limits of aortic tissue at a diameter of 6 cm; (4) by the time a TAA reaches a clinical diameter of 6 cm, 34 percent of affected patients have suffered dissection or rupture; (5) extreme physical exertion or severe emotion often precipitate acute dissection; and (6) single nucleotide polymorphisms (SNPs) and RNA expression profile changes are being identified that predispose a patient to @DISEASE$ and can serve as biomarkers for screening for this virulent disease.", "text_with_entity_marker": "Analysis yielded the following Yale-generated observations: (1) TAA is a genetic disease with a predominantly autosomal dominant mode of inheritance; (2) matrix metalloproteinase ([E1]@GENE$[/E1]) enzymes are activated in the pathogenesis of TAA; (3) wall tension in TAA approaches the tensile limits of aortic tissue at a diameter of 6 cm; (4) by the time a TAA reaches a clinical diameter of 6 cm, 34 percent of affected patients have suffered dissection or rupture; (5) extreme physical exertion or severe emotion often precipitate acute dissection; and (6) single nucleotide polymorphisms (SNPs) and RNA expression profile changes are being identified that predispose a patient to [E2]@DISEASE$[/E2] and can serve as biomarkers for screening for this virulent disease.", "text_with_typed_entity_marker": "Analysis yielded the following Yale-generated observations: (1) TAA is a genetic disease with a predominantly autosomal dominant mode of inheritance; (2) matrix metalloproteinase ([GENE]@GENE$[/GENE]) enzymes are activated in the pathogenesis of TAA; (3) wall tension in TAA approaches the tensile limits of aortic tissue at a diameter of 6 cm; (4) by the time a TAA reaches a clinical diameter of 6 cm, 34 percent of affected patients have suffered dissection or rupture; (5) extreme physical exertion or severe emotion often precipitate acute dissection; and (6) single nucleotide polymorphisms (SNPs) and RNA expression profile changes are being identified that predispose a patient to [DISEASE]@DISEASE$[/DISEASE] and can serve as biomarkers for screening for this virulent disease.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [180, 186], "entity_1_idx_in_text_with_entity_marker": [184, 190], "entity_1_idx_in_text_with_typed_entity_marker": [186, 192], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [676, 685], "entity_2_idx_in_text_with_entity_marker": [689, 698], "entity_2_idx_in_text_with_typed_entity_marker": [698, 707], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "test_3_34", "text": "Analysis yielded the following Yale-generated observations: (1) TAA is a genetic disease with a predominantly autosomal dominant mode of inheritance; (2) @GENE$ (MMP) enzymes are activated in the pathogenesis of TAA; (3) wall tension in TAA approaches the tensile limits of aortic tissue at a diameter of 6 cm; (4) by the time a TAA reaches a clinical diameter of 6 cm, 34 percent of affected patients have suffered dissection or rupture; (5) extreme physical exertion or severe emotion often precipitate acute dissection; and (6) single nucleotide polymorphisms (SNPs) and RNA expression profile changes are being identified that predispose a patient to @DISEASE$ and can serve as biomarkers for screening for this virulent disease.", "text_with_entity_marker": "Analysis yielded the following Yale-generated observations: (1) TAA is a genetic disease with a predominantly autosomal dominant mode of inheritance; (2) [E1]@GENE$[/E1] (MMP) enzymes are activated in the pathogenesis of TAA; (3) wall tension in TAA approaches the tensile limits of aortic tissue at a diameter of 6 cm; (4) by the time a TAA reaches a clinical diameter of 6 cm, 34 percent of affected patients have suffered dissection or rupture; (5) extreme physical exertion or severe emotion often precipitate acute dissection; and (6) single nucleotide polymorphisms (SNPs) and RNA expression profile changes are being identified that predispose a patient to [E2]@DISEASE$[/E2] and can serve as biomarkers for screening for this virulent disease.", "text_with_typed_entity_marker": "Analysis yielded the following Yale-generated observations: (1) TAA is a genetic disease with a predominantly autosomal dominant mode of inheritance; (2) [GENE]@GENE$[/GENE] (MMP) enzymes are activated in the pathogenesis of TAA; (3) wall tension in TAA approaches the tensile limits of aortic tissue at a diameter of 6 cm; (4) by the time a TAA reaches a clinical diameter of 6 cm, 34 percent of affected patients have suffered dissection or rupture; (5) extreme physical exertion or severe emotion often precipitate acute dissection; and (6) single nucleotide polymorphisms (SNPs) and RNA expression profile changes are being identified that predispose a patient to [DISEASE]@DISEASE$[/DISEASE] and can serve as biomarkers for screening for this virulent disease.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [154, 160], "entity_1_idx_in_text_with_entity_marker": [158, 164], "entity_1_idx_in_text_with_typed_entity_marker": [160, 166], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [655, 664], "entity_2_idx_in_text_with_entity_marker": [668, 677], "entity_2_idx_in_text_with_typed_entity_marker": [677, 686], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
